Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PC-6500 (Griffithsin Gel) in Healthy Women
NCT02875119Phase 1Completed
- Sponsor
- Population Council
- Start
- Oct 2017
- Primary completion
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Griffithsin Gel with Placebo Gel (2 arms). Primary endpoint: Treatment Emergent Adverse Events at 10 months. Started Oct 2017; status: completed.
02
Drugs
Griffithsin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02875119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02875119.